Trials / Completed
CompletedNCT01926353
Polyacrylate Polyalcohol Copolymer for Vesicoureteral Reflux
Tissue Bulking Agent -Polyacrylate Polyalcohol Copolymer for Endoscopic Correction of Vesicoureteral Reflux in Children: A Comparative Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 25 (actual)
- Sponsor
- St. Luke's Medical Center, Philippines · Academic / Other
- Sex
- All
- Age
- 1 Year – 5 Years
- Healthy volunteers
- Not accepted
Summary
Endoscopic correction of VUR has gained its popularity due to its less invasiveness, associated low morbidity and short hospital stay. Although short term follow-up had justified their efficacy; however, long term recurrence and complications following endoscopic correction were also being reported in the literatures (6). Currently, there are insufficient evidences on the efficacy and safety of biocompatible tissue augmenting materials used for endoscopic correction of VUR; particularly on the new tissue bulking agents. (6) Polyacrylate polyalcohol copolymer (PPC)-Vantris ® (Promedon, Cordoba, Argentina) is the newest tissue augmenting biocompatible Acrylics used for endoscopic correction of VUR.
Conditions
Timeline
- Start date
- 2013-07-01
- Primary completion
- 2014-02-01
- Completion
- 2014-02-01
- First posted
- 2013-08-20
- Last updated
- 2015-04-07
Locations
1 site across 1 country: Philippines
Source: ClinicalTrials.gov record NCT01926353. Inclusion in this directory is not an endorsement.